SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-093275
Filing Date
2024-04-11
Accepted
2024-04-11 16:26:28
Documents
7
Period of Report
2024-05-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A d512281ddef14a.htm DEF 14A 452064
2 GRAPHIC g512281dsp047.jpg GRAPHIC 223402
3 GRAPHIC g512281dsp048.jpg GRAPHIC 118308
4 GRAPHIC g512281g0409054031568.jpg GRAPHIC 4056
5 GRAPHIC g512281g0409054031780.jpg GRAPHIC 2404
6 GRAPHIC g512281g34a01.jpg GRAPHIC 78849
7 GRAPHIC g512281g34a02.jpg GRAPHIC 84627
  Complete submission text file 0001193125-24-093275.txt   1158629
Mailing Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065
Business Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065 240-327-0603
Arcellx, Inc. (Filer) CIK: 0001786205 (see all company filings)

IRS No.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41259 | Film No.: 24838820
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)